SHP Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$235K Hold
9,754
– – 0.02% 274
2026
Q2
$235K Buy
9,754
+143
+1% +$3.74K 0.02% 274
2026
Q1
$270K Buy
9,611
+1,602
+20% +$42.7K 0.02% 213
2025
Q4
$199K Buy
+8,009
New +$202K 0.02% 255

Other funds holding PFE

SHP Wealth Management's PFE Position: Q3 2026 in Review

SHP Wealth Management held its Pfizer (PFE) position steady in Q3 2026 at 9,754 shares worth $235K. The position accounts for 0.02% of the portfolio, ranked #274.

SHP Wealth Management first reported a position in PFE in Q4 2025 and has held it in 4 quarters since. The position peaked at $270K in Q1 2026. 2,915 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • SHP Wealth Management held 9,754 shares of Pfizer worth $235K as of Q3 2026.
  • SHP Wealth Management left its Pfizer share count unchanged in Q3 2026.
  • Pfizer made up 0.02% of SHP Wealth Management's portfolio in Q3 2026, its #274 holding.
  • SHP Wealth Management first reported a position in Pfizer in Q4 2025 and has held it in 4 quarters since.
  • SHP Wealth Management's Pfizer position peaked at $270K in Q1 2026.
  • 2,915 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on SHP Wealth Management's 13F filing for Q3 2026, filed 19 Nov 2026.